Literature DB >> 18949259

Pediatric multiple sclerosis: analysis of clinical and epidemiological aspects according to National MS Society Consensus 2007.

Maria Lúcia Brito Ferreira1, Maria Iris Morais Machado, Maria José Guedes Dantas, Alvaro José Porto Moreira, Adélia Maria de Miranda Henriques Souza.   

Abstract

OBJECTIVE: To describe the epidemiological and clinical characteristics of child/adolescence multiple sclerosis (MS).
METHOD: According to a descriptive, cohort study, with comparison of groups, data of 31 cases of child/adolescent MS, diagnosed at State Reference Center for Demyelinating Diseases-Hospital da Restauração, Recife, Pernambuco, Brazil, from 1987 to July 2007, were analyzed. The variables were: sex, initial symptoms, time for diagnosis, time of disease onset (early childhood, later childhood and adolescence), time of follow-up, number of relapses, relapses index and disability. Using SPSS software, version 13.0, t Student and Mann-Whitney tests were performed, with significance level of 0.05.
RESULTS: There were 3 (9.7%) cases of early childhood MS, 9 (29%), of late childhood MS, and 19 (61.3%), of adolescence MS. The general sex rate female: male was 1.8:1, varying according to age of onset. The predominant deficits were motor (12; 38.7%) and brainstem/cerebellum (7; 22.5%) especially on subsequent relapses of relapsing/remitting form. Time for diagnosis and average relapses index were higher in early childhood than in adolescence class (p=0.049 and p=0.028, respectively). Disability was higher for primary and secondary MS, as well as for early childhood.
CONCLUSION: Early childhood MS presents proper and different characteristics from adults, consisting in a difficult diagnosis that demands aid of expert neurologist on MS.

Entities:  

Mesh:

Year:  2008        PMID: 18949259     DOI: 10.1590/s0004-282x2008000500011

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  Personalized Disease Monitoring in Pediatric Onset Multiple Sclerosis Using the Saliva Free Light Chain Test.

Authors:  Esther Ganelin-Cohen; Evgeny Tartakovsky; Ely Klepfish; Sizilia Golderman; Ayal Rozenberg; Batia Kaplan
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

2.  Neuroplasticity in Early Onset Multiple Sclerosis.

Authors:  Abdorreza Naser Moghadasi
Journal:  Iran J Child Neurol       Date:  2014

Review 3.  Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.

Authors:  Sneham Tiwari; Jessica Lapierre; Chet Raj Ojha; Kyle Martins; Tiyash Parira; Rajib Kumar Dutta; Allen Caobi; Luis Garbinski; Yasemin Ceyhan; Maria Esteban-Lopez; Nazira El-Hage
Journal:  J Neurosci Res       Date:  2018-09-11       Impact factor: 4.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.